Thomas Jefferson University Hospital — Philadelphia, Pennsylvania

Public research footprint of Thomas Jefferson University Hospital, compiled from the ClinicalTrials.gov public registry.

750

Registered studies

297

Active

127

Recruiting now

315

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Locally Advanced Unresectable Digestive System Neuroendocrine Neoplasm · Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6… · Lung Non-Small Cell Carcinoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT07215910 — Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Thomas Jefferson University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.